BlueRock Therapeutics
A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity.
1
Funding Rounds
$225.0m
Money raised
Overview
A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity.
-
Website:
- Business model: B2B
- Headquarters: New York City
- Social accounts:
Industries
BlueRock Therapeutics is active in the following industries:
- Induced pluripotent stem cell
- Regenerative medicine
- Healthcare
- Cell therapy
- Therapeutics
- Therapy
- Autoimmune disease
- Cardiovascular disease
- Biomedical engineering
- Biopharmaceutical
- Medicine
- Technology
- Anti-Aging
- Biology
- Biotechnology
- Cardiology
- Internal medicine
- Genomics
- Genome editing
- Tissue engineering
- Stem cell technology
- Engineering
- Stem-cell therapy
- Immunotherapy